Understand the Importance of ANVISA’s Role in the Global Product Regulation

ANVISA’s role in this committee reaffirms the importance of efficient regulation and international cooperation to ensure the safety of medical products. The current work plan (2024-2025) includes ten priority activities, including the development of technologies for detecting irregular products, risk awareness strategies and monitoring of informal markets.

Impact of WHO Meetings on Product Regulation

The growing concern about counterfeit medical products reinforces the need for strict regulation. During the technical sessions, experts discussed solutions to identify substandard products, strengthen inspection strategies and develop guidelines to mitigate risks associated with the marketing of irregular devices.

QR Group closely monitors these changes and offers support to foreign manufacturers who wish to ensure regulatory compliance in Brazil. With expertise in the regulation of medical devices with ANVISA, the company acts strategically to avoid bureaucratic obstacles and ensure an efficient registration process.

How does QR Group Help with the Product Regulation?

With a highly qualified team, QR Group provides specialized consultancy to regularize health products in Brazil, ensuring that foreign companies comply with all ANVISA requirements. Among the services offered are:

• Analysis and adaptation of regulatory documentation.
• Support in the petition process with ANVISA.
• Monitoring of regulatory updates to anticipate future requirements.
• Development of strategies to speed up the entry of products into the Brazilian market.

Stay Updated and Ensure Compliance with QR Group

International discussions on the regulation of medical products reinforce the need for specialized monitoring. If you are a manufacturer and want to ensure the compliance of your product with ANVISA, count on QR Group. Contact us to learn more about our solutions and ensure a safe and efficient regulatory process.

Source: ANVISA